Showing 5511-5520 of 7758 results for "".
- Oculus Innovative Sciences Receives European CE Mark for Use of Microcyn to Treat Mild to Moderate Acnehttps://practicaldermatology.com/news/20140204-oculus_innovative_sciences_receives_european_ce_mark_for_use_of_microcyn_to_treat_mild_to_moderate_acne/2459350/
- Acella Pharmaceuticals Announces Approval and Launch of Loutrex Topical Creamhttps://practicaldermatology.com/news/20140131-acella_pharmaceuticals_announces_approval_and_launch_of_loutrex_topical_cream/2459352/
- Study Finds Prevalence of Indoor Tanning Common in US, Europe, and Australiahttps://practicaldermatology.com/news/20140130-study_finds_prevalence_of_indoor_tanning_common_in_us_europe_and_australia/2459355/
- FDA Approves Celluma as OTC Light Therapy Device to Treat Acne and Morehttps://practicaldermatology.com/news/20140121-fda_approves_celluma_as_otc_light_therapy_device_to_treat_acne_and_more/2459366/
- Scioderm Initiates Phase IIB Study of SD-101 to Treat Epidermolysis Bullosahttps://practicaldermatology.com/news/20140107-scioderm_initiates_phase_iib_study_of_sd-101_to_treat_epidermolysis_bullosa/2459377/
- Consumer Survey Reveals Widespread Problem of Excessive Sweating and Desire for New Topical Botulinum Toxin Treatmenthttps://practicaldermatology.com/news/20131118-consumer_survey_reveals_widespread_problem_of_excessive_sweating_and_desire_for_new_topical_botulinum_toxin_treatment/2459412/Anterios, Inc announced survey results about current consumer sentiment around exces
- Signum Dermalogix Receives Grant for the Development of Atopic Dermatitis Therapeuticshttps://practicaldermatology.com/news/20131114-signum_dermalogix_receives_grant_for_the_development_of_atopic_dermatitis_therapeutics/2459415/The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded Signum Dermalogix, Inc. (Dermalogix) a Small Business Innovat
- Myriad Genetics Launches myPath Melanoma Diagnostic Testhttps://practicaldermatology.com/news/20131114-myriad_genetics_launches_mypath_melanoma_diagnostic_test/2459416/
- Phase I Trial for Implantable Melanoma Vaccine Beginshttps://practicaldermatology.com/news/20130910-phase_i_trial_for_implantable_melanoma_vaccine_begins/2459466/
- Novan Awarded Contract by BARDA to Develop a Medical Countermeasure for Thermal Burnshttps://practicaldermatology.com/news/20130829-novan_awarded_contract_by_barda_to_develop_a_medical_countermeasure_for_thermal_burns/2459472/